Giusy Carfi Pavia

Giusy Carfi Pavia

Auto-generated profile, based on publicly available information

Giusy Carfi Pavia

Neurology, Epilepsy and Movement Disorders Unit Bambino Gesù Children's Hospital, Scientific Institute for Research and Health Care, Full Member of European Reference Network on Rare and Complex Epilepsies EpiCARE Rome Italy

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2019 in Epilepsy & Behavior
Verified
Journal Article
Closed access
LPLuca De Palma
Luca De Palma
NPNicola Pietrafusa
Nicola Pietrafusa
FGFrancesca Gozzo
Francesca Gozzo
CBCarmen Barba
Carmen Barba
GCGiusy Carfi-Pavia
Giusy Carfi-Pavia
NSNicola Specchio
Nicola Specchio

10 June 2019 in Pediatric Drugs
Verified
Journal Article
Closed access
PDF file
NPNicola Pietrafusa
Nicola Pietrafusa
AFAlessandro Ferretti
Alessandro Ferretti
MTMarina Trivisano
Marina Trivisano
LPLuca De Palma
Luca De Palma
CCCostanza Calabrese
Costanza Calabrese
NSNicola Specchio
Nicola Specchio

12 November 2019 in Epilepsia
Verified
Journal Article
Closed access
PDF file
NSNicola Specchio
Nicola Specchio
NPNicola Pietrafusa
Nicola Pietrafusa
MBMarcello Bellusci
Marcello Bellusci
MTMarina Trivisano
Marina Trivisano
ABAntonella Benvenga
Antonella Benvenga
FVFederico Vigevano
Federico Vigevano

17 September 2024 in Epilepsia
Verified
Journal Article
Open access
PSPaolo Surdi
Paolo Surdi
MTMarina Trivisano
Marina Trivisano
ADAngela De Dominicis
Angela De Dominicis
MMMattia Mercier
Mattia Mercier
LPLudovica Maria Piscitello
Ludovica Maria Piscitello
NSNicola Specchio
Nicola Specchio
Objective: Developmental and epileptic encephalopathies (DEEs) are neurological disorders characterized by developmental impairment and epilepsy. Our study aims to assess disease progression by comparing clinical findings, electroencephalography (EEG), and neuropsychological data from seizure onset to the last follow‐up evaluation.Methods: We retrospectively reviewed patients with genetic DEEs who were followed‐up at the epilepsy unit of Bambino Gesù Children's Hospital, Rome. We collected information regarding gender, family history, genetic variant, age at onset and at last follow‐up, neurological examination, type of seizure, drug resistance, occurrence of status epilepticus, and movement and cognitive and behavioral disorders. We compared EEG background activity, epileptiform abnormalities, and cognitive functions between seizure onset and the last follow‐up evaluation using the McNemar‐Bowker test (α = 5%).Results: A total of 160 patients (94 female) were included. Genetic analysis revealed a spectrum of pathogenic variants, with SCN1A being the most prevalent (25%). The median age at seizure onset and at the last follow‐up was 0.37 (interquartile range [IQR]: 0.09–0.75) and 8.54 years (IQR: 4.32–14.55), respectively. We documented a statistically significant difference in EEG background activity (p = .017) and cognitive impairment (p = .01) from seizure onset to the last follow‐up evaluation. No significant differences were detected for epileptiform abnormalities (p = .2). In addition, high prevalence rates were observed for drug resistance (81.9%), movement disorders (60.6%), behavioral and autism spectrum disorders (45%), neurological deficits (31.3%), and occurrence of status epilepticus (23.1%).Significance: Our study provides evidence that a clinical progression may appear in genetic DEEs, manifesting as development or worsening of cognitive impairment and disruption of EEG background activity. These results highlight the challenging clinical course and the importance of early intervention and personalized care in the management of patients with DEEs.

2 August 2025 in Epilepsia
Verified
Journal Article
Open access
CCCinzia Correale
Cinzia Correale
MMMattia Mercier
Mattia Mercier
SCSimona Cappelletti
Simona Cappelletti
NPNicola Pietrafusa
Nicola Pietrafusa
CFChiara Falamesca
Chiara Falamesca
NSNicola Specchio
Nicola Specchio
Objective: Parental stress in pediatric epilepsy is often linked to seizure‐related factors. However, less is known about the contribution of child cognitive functioning, behavioral symptoms, and treatment complexity to caregiver burden. This study aimed to investigate how these variables, along with sociodemographic factors, predict perceived parental stress. Methods: We conducted a cross‐sectional study including 117 children with epilepsy and 149 caregivers. Cognitive functioning was classified through standardized assessments; behavioral symptoms were evaluated using the Child Behavior Checklist (CBCL); and parental stress was measured with the Parenting Stress Index–Short Form (PSI‐SF). Clinical variables included epilepsy etiology, seizure control, drug resistance, and medication regimen. Group comparisons and regression models were used to explore predictors of stress. Results: Higher stress levels were observed among parents of children with moderate intellectual disability, compared to those with normal cognition. Clinical‐range behavioral symptoms—especially internalizing problems—were significantly associated with elevated stress across PSI domains. Parents of children receiving polytherapy or with drug‐resistant epilepsy reported higher levels of dysfunctional parent–child interaction. Lower educational attainment was also linked to greater stress. Although no stress differences emerged by caregiver gender, most participants were mothers. Notably, elevated Defensing Responding scores suggested a potential underreporting of caregiver burden. Significance: These findings indicate that child cognitive and behavioral characteristics, along with treatment complexity, play a greater role in parental stress than core epilepsy variables alone. It is notable that, the tendency to underreport stress may obscure caregiver needs, especially in clinical settings relying solely on self‐report measures. Routine caregiver screening and multimodal assessment strategies—including interviews and observations—should be integrated into epilepsy care pathways. Supporting caregiver well‐being is essential to sustaining family functioning. It aligns with the priorities outlined in the World Health Organization (WHO) Intersectoral Global Action Plan (IGAP), which highlights caregiver support as a key pillar of person‐ and family‐centered care for neurological conditions.

2 September 2024 in Epilepsia Open
Verified
Journal Article
Open access
SCSimona Cappelletti
Simona Cappelletti
CCCinzia Correale
Cinzia Correale
MMMattia Mercier
Mattia Mercier
GPGiusy Carfi Pavia
Giusy Carfi Pavia
CFChiara Falamesca
Chiara Falamesca
NSNicola Specchio
Nicola Specchio
Objective: The aim of this study is to describe the pre‐ and post‐operative developmental and intellectual functions in a cohort of patients who underwent surgery for drug‐resistant epilepsy (DRE) before the age of 5 years.Method: We retrospectively reviewed the medical records and neurodevelopmental assessments of a cohort of 80 surgically treated pediatric patients with DRE. We included patients if they had at least one pre‐ and one post‐surgical neuropsychological assessments; 27 met the inclusion criteria. We evaluated Developmental Quotient (DQ) and Intelligence Quotient (IQ) before and after surgery. We identified two groups based on psychological evaluation outcome: Group 1, with stable or improved developmental and intellectual functions, and Group 2, experiencing developmental and intellectual loss.Results: The mean age at seizure onset was 1.2 ± 1.0 years, and the mean age at surgery was 2.9 ± 1.2 years. At the last follow‐up (mean 4 years, SD ± 2), 19/27 (70%) patients were seizure‐ and drug‐free; 18/27 patients (67%) fit in Group 1, and 9/27 (33%) fit in Group 2. The mean age at surgery was 2.6 years (SD ± 1.1; range 1.2–5.1) in Group 1 and 3.4 years in Group 2 (SD ± 1.1; range 1.6–5.0). Group 1 had a lower pre‐operative DQ/IQ total score than Group 2 (median DQ/IQ respectively 82 vs 108, p = 0.05). Between pre‐ and post‐assessments, we found that in Group 1, Performance scores improved (82.7 vs 102, p = 0.001), while in Group 2, the Total and Verbal scores worsened (respectively 108 vs 75, p = 0.008, and 100 vs 76, p = 0.021).Significance: Our study's results emphasize the positive impact of surgery before the age of 5 years on developmental and intellectual outcomes. Despite limitations such as a small sample size, lack of a control group, and diverse etiologies, our findings support the crucial role of early intervention in preserving or enhancing developmental and intellectual functions in young patients with DRE.Plain Language Summary: This retrospective study, conducted at the Bambino Gesù Children Hospital in Italy, reports neuropsychological and developmental and/or cognitive data for children undergoing early epilepsy surgery (before the age of 5). It found that children with lower developmental or cognitive profiles gained the highest scores on post‐operative neuropsychological evaluations. This study provides information on the potential benefits of early surgery in shortening the duration of epilepsy, preventing or arresting deterioration, and enhancing plasticity and recovery.